Metrics of Antimicrobial Stewardship Programs
Metrics of Antimicrobial Stewardship Programs
复制标题
DOI：
10.1016/j.mcna.2018.05.008
复制
发表时间：
2018-09-01
影响因子：
5.9
通讯作者：
Brotherton, Amy L.
中科院分区：
文献类型：
--
作者：
Brotherton, Amy L.
需要适当的指标来衡量抗菌药物管理计划的质量、临床和财务影响。这些指标通常分为抗生素使用指标、过程指标、质量指标、成本和临床结果指标。传统上，抗菌药物管理指标侧重于抗生素使用、抗生素成本和工艺措施。随着医疗保健改革，实践应该转向关注管理计划的临床影响，而不是财务影响。本文综述了文献中描述的各种抗菌剂管理指标，支持这些指标的证据，围绕指标的争议以及未来研究的必要领域。
Appropriate metrics are needed to measure the quality, clinical, and financial impacts of antimicrobial stewardship programs. Metrics are typically categorized into antibiotic use measures, process measures, quality measures, costs, and clinical outcome measures. Traditionally, antimicrobial stewardship metrics have focused on antibiotic use, antibiotic costs, and process measures. With health care reform, practice should shift to focusing on clinical impact of stewardship programs over financial impact. This article reviews the various antimicrobial stewardship metrics that have been described in the literature, evidence to support these metrics, controversies surrounding metrics, and areas in which future research is necessary.